Global Ophthalmic Drugs Market Size & Outlook, 2023-2030

The ophthalmic drugs industry worldwide is expected to reach a projected revenue of US$ 66,064.5 million by 2030. A compound annual growth rate of 8.3% is expected of the worldwide ophthalmic drugs industry from 2024 to 2030.
Revenue, 2023 (US$M)
$37,823.0
Forecast, 2030 (US$M)
$66,064.5
CAGR, 2024 - 2030
8.3%
Report Coverage
Worldwide

Global ophthalmic drugs market, 2018-2030 (US$M)

Global ophthalmic drugs market highlights

  • The global ophthalmic drugs market generated a revenue of USD 37,823.0 million in 2023 and is expected to reach USD 66,064.5 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 8.3% by 2030.
  • In terms of segment, anti-vegf agents accounted for a revenue of USD 12,370.2 million in 2023.
  • Gene & Cell Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 37,823.0 million
Market revenue in 2030USD 66,064.5 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentAnti-vegf agents
Fastest growing segmentGene & Cell Therapy
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Gene & Cell Therapy

Other key industry trends

  • In terms of revenue, the North America accounted for 45.0% of the global ophthalmic drugs market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 25,551.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ophthalmic Drugs Market Companies

Name Profile # Employees HQ Website

Global ophthalmic drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.


Anti-vegf agents was the largest segment with a revenue share of 32.71% in 2023. Horizon Databook has segmented the Global ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma, gene & cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Ophthalmic Drugs Drug class Outlook (Revenue, USD Million, 2018-2030)
    • Anti-Allergy
    • Anti-VEGF agents
    • Anti-inflammatory
      • Non-steroidal drugs
      • Steroids
    • Anti-glaucoma
    • Gene & Cell Therapy
    • Others
  • Global Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2018-2030)
    • Dry eye
    • Allergies
    • Glaucoma
    • Infection
    • Retinal Disorders
      • Macular Degeneration
      • Diabetic Retinopathy
      • Others
    • Uveitis
    • Others
  • Global Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Topical
    • Local Ocular
      • Subconjunctival
      • Intravitreal
      • Retrobulbar
      • Intracameral
    • Sytemic
  • Global Ophthalmic Drugs Dosage Type Outlook (Revenue, USD Million, 2018-2030)
    • Gels
    • Eye solutions & suspensions
    • Capsules & Tablets
    • Eye drops
    • Ointments

Reasons to subscribe to Global ophthalmic drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global ophthalmic drugs market databook

  • Our clientele includes a mix of ophthalmic drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global ophthalmic drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global ophthalmic drugs market size, by regions, 2018-2030 (US$M)

Top 10 countries: Ophthalmic drugs market size, 2023 (US$M)

Global ophthalmic drugs market share, by drug class, 2023 & 2030 (%, US$M)

Ophthalmic drugs market: Opportunity assessment by country

Global ophthalmic drugs market, by region, 2023 (US$M)

Global ophthalmic drugs market size, by regions, 2018-2030 (US$M)

Drug class 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 14,742.4 15,971.7 13,971.8 15,164.9 16,206.4 17,014.9 18,256.0 19,601.9 21,062.4 22,648.6 24,372.3 26,247.1 28,287.6 7.5%
Europe 8,231.8 8,945.2 7,849.1 8,545.6 9,161.0 9,648.4 10,385.1 11,186.7 12,059.3 13,010.2 14,047.0 15,178.4 16,414.0 7.9%
Asia Pacific 6,341.1 7,042.8 6,314.3 7,022.3 7,687.4 8,265.4 9,079.9 9,979.7 10,974.4 12,074.6 13,292.5 14,641.4 16,136.6 10.0%
Latin America 1,427.2 1,561.6 1,379.7 1,512.5 1,632.7 1,731.4 1,876.6 2,035.4 2,209.4 2,400.2 2,609.4 2,839.2 3,091.7 8.6%
MEA 938.8 1,031.6 915.3 1,007.6 1,092.2 1,163.0 1,265.6 1,378.2 1,502.0 1,638.1 1,787.9 1,952.8 2,134.6 9.1%
Overall 31,681.2 34,552.9 30,430.2 33,252.9 35,779.6 37,823.0 40,863.2 44,181.9 47,807.6 51,771.6 56,109.1 60,858.9 66,064.5 8.3%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more